SEC filing · 8-K

Gain Therapeutics, Inc.: Executive or director change

Gianluca Fuggetta resigned as Principal Financial Officer, and CEO Gene Mack was appointed interim CFO.

Filed September 28, 2026

Neutral news

What happened

On September 22, 2026, Senior Vice President of Finance Gianluca Fuggetta notified the company of his resignation effective September 30, 2026.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov All documents of this filing

Back to Gain Therapeutics, Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.